Contineum Therapeutics, Inc. - PE Ratio

The PE Ratio as of August 2026 (TTM) for Contineum Therapeutics, Inc. (CTNM) is -7.92

According to Contineum Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -7.92. This represents a change of 2.28% compared to the average of -7.74 of the last 4 quarters.

Contineum Therapeutics, Inc. (CTNM) Historical PE Ratio (quarterly & annually)

How has CTNM PE Ratio performed in the past?

The mean historical PE Ratio of Contineum Therapeutics, Inc. over the last ten years is 14.99. The current -7.92 PE Ratio has changed -5384.30% with respect to the historical average. Over the past ten years (40 quarters), CTNM's PE Ratio was at its highest in in the June 2023 quarter at 2.38. The PE Ratio was at its lowest in in the December 2023 quarter at -81.05.

Contineum Therapeutics, Inc. (CTNM) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Contineum Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Contineum Therapeutics, Inc. (CTNM) Average PE Ratio

How has CTNM PE Ratio performed in the past?

The current PE Ratio of Contineum Therapeutics, Inc. (CTNM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Contineum Therapeutics, Inc. (CTNM) PE Ratio vs. Peers

How is CTNM’s PE Ratio compared to its peers?

Contineum Therapeutics, Inc.’s PE Ratio is less than Mereo BioPharma Group plc (-1.35), less than Kyverna Therapeutics, Inc. (-2.31), less than Lexeo Therapeutics, Inc. Common Stock (-3.03), less than Silence Therapeutics plc (-2.62), less than AC Immune S.A. (-2.82), greater than Alto Neuroscience, Inc. (-11.24), less than Aldeyra The (-3.48), less than Capricor Therapeutics, Inc. (-1.68), greater than Candel Therapeutics, Inc. (-10.47), greater than Amarin Corporation plc (-10.12),

Build a custom stock screener for Contineum Therapeutics, Inc. (CTNM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Contineum Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Contineum Therapeutics, Inc. (CTNM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Contineum Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.